AE-QoL - Angioedema Quality of Life Score

Basic description

Developed in 2012

Authors

Weller K; Groffik A; Magerl M; Tohme N; Martus P; Krause K; Metz M; Staubach P; Maurer M

MOXIE Company

Objective

To measure health-related quality of life (HRQoL) impairment in patients with recurrent angioedema

Therapeutic area

Cardiovascular Diseases
Skin and Connective Tissue Diseases
Immune System Diseases

Therapeutic indication

Hereditary Angioedema
Urticaria

Chronic spontaneous urticaria (csU), hereditary angioedema (HAE1&2)

Type of Clinical Outcome Assessment (COA)

Original language(s)

German for Germany

Translations

23 translation(s)

Bibliographic reference(s) of the original questionnaire

Weller K, Groffik A, Magerl M, et al. Development and construct validation of the angioedema quality of life questionnaire. Allergy. 2012 Oct;67(10):1289-98 (Full Text Article)

Weller K, Magerl M, Peveling-Oberhag A, et al. The Angioedema Quality of Life Questionnaire (AE-QoL) - Assessment of Sensitivity to Change and Minimal Clinically Important Difference. Allergy. 2016 Aug;71(8):1203-9 (PubMed Abstract)

Angioedema Quality of Life Score (AE-QoL)

Basic description

Member Access

YOU MIGHT ALSO BE INTERESTED IN:

MAPI RESEARCH TRUST

Angioedema Quality of Life Score (AE-QoL)

Basic description

Member Access

Already a subscriber

Subscribe to PROQOLID to access to full information

YOU MIGHT ALSO BE INTERESTED IN: